Skip to main content

Table 3 Demographic data of individuals with antemortem CSF assessment

From: NG2 cells, a new trail for Alzheimer’s disease mechanisms?

Characteristics Control (n=36) AD (n=47)
M/F (n) 17 / 19 13 / 34
Age at investigation (yrs) 61 ± 9 *** 77 ± 7
MMSE 28 ± 1 *** 20 ± 4
APOEϵ4 carriers (%)1,# 31 77
Aβ1–42 (ng/L) 659 ± 230 *** 355 ± 100
T-Tau (ng/L) 279 ± 136 *** 821 ± 322
P-Tau (ng/L)2 47 ± 19 *** 104 ± 39
NG2 (μg/ml)3 1.90 ± 0.07 *1.63 ± 0. 06
  1. Data are presented as mean± SD. 1Data missing on n=2 control. 2 Data missing on n=2 control, n=10 AD. # Individuals carrying one or two APOEϵ4 alleles. *** Indicates a significant difference at the p<0.001 level compared to controls using ANOVA. 3Results are age-adjusted. * Indicates a significant difference at the p<0.05 level compared to controls using ANCOVA.